Discussion: Schizophrenia - diverse etiologies, common pathogenesis

  • T. H. McGlashan
  • R. E. Hoffman
Conference paper


In this session on the Precursors of Schizophrenia our speakers have presented data about pathways to schizophrenia that are at first glance quite diverse. Indeed, the time-honored notion that schizophrenia is a heterogeneous group of disorders appears validated by the diversity of the accumulated findings.


Bipolar Disorder Synaptic Connectivity Synaptic Density Neurologic Soft Sign Domestic Chick 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry 156:1646–1649PubMedGoogle Scholar
  2. 2.
    Bock J, Braun K (1999) Filial imprinting in domestic chicks is associated with spine pruning in the associative area, dorsocaudal neostriatum. European Journal of Neuroscience 11:2566–2570PubMedCrossRefGoogle Scholar
  3. 3.
    Bock J, Wolf A, Braun K (1996) Influence of the N-Methyl-D-aspartate receptor antagonist DL-2-amino-5-phosphonovaleric acid on auditory filial imprinting in the domestic chick. Neurobiology of Learning and Memory 65:177–188PubMedCrossRefGoogle Scholar
  4. 4.
    Cardno AG, Rijsdijk FV, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry 159: 539–545PubMedCrossRefGoogle Scholar
  5. 5.
    Feinberg I (1983) Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research 17:319–334CrossRefGoogle Scholar
  6. 6.
    Hoffman RE (1987) Computer simulation of neural information processing and the schizophrenia-mania dichotomy. Archives of General Psychiatry 44:178–188PubMedCrossRefGoogle Scholar
  7. 7.
    Hoffman RE, McGlashan TH (1997) Synaptic elimination, neurodevelopment, and the mechanism of hallucinated “voices” in schizophrenia. American Journal of Psychiatry 154:1683–1689PubMedGoogle Scholar
  8. 8.
    Hoffman RE, McGlashan TH (1993) Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophrenia Bulletin 19:119–140PubMedCrossRefGoogle Scholar
  9. 9.
    Huttenlocher PR (1979) Synaptic density in the human frontal cortex: developmental changes and effects of aging. Brain Research 163:195–205PubMedCrossRefGoogle Scholar
  10. 10.
    Huttenlocher PR, Dabholkar AS (1997) Regional differences in synaptogenesis in human cerebral cortex. Journal of Comparative Neurology 387:167–178PubMedCrossRefGoogle Scholar
  11. 11.
    Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Archives of General Psychiatry 51:199–214PubMedCrossRefGoogle Scholar
  12. 12.
    McGlashan TH, Hoffman RE (2000) Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry 57:637–648PubMedCrossRefGoogle Scholar
  13. 13.
    McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM (1995) Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 15:277–281PubMedCrossRefGoogle Scholar
  14. 14.
    Satel SL, Edell WS (1991) Cocaine-induced paranoia and psychosis proneness. American Journal of Psychiatry 148:1708–1711PubMedGoogle Scholar
  15. 15.
    Tatetsu S (1972) Methamphetamine psychosis. In: Ellinwood EH, Cohen S (eds) Current Concept on Amphetamine Abuse. DHEW Publication No. (HSM) 72–9085. US Government Printing Office, Washington, DCGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • T. H. McGlashan
    • 1
  • R. E. Hoffman
    • 1
  1. 1.Yale University School of MedicineUSA

Personalised recommendations